Guylaine Hoffner

Dr. Guylaine Hoffner


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 August 2005 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
GHGuylaine Hoffner
Guylaine Hoffner
MIMarie‐Laure Island
Marie‐Laure Island
PDPhilippe Djian
Philippe Djian

22 October 2014 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
GHGuylaine Hoffner
Guylaine Hoffner
PDPhilippe Djian
Philippe Djian

18 February 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SIS. Iuchi
S. Iuchi
GHGuylaine Hoffner
Guylaine Hoffner
PVP. Verbeke
P. Verbeke
PDP. Djian
P. Djian
HGH. Green
H. Green
Neurological diseases resulting from proteins containing expanded polyglutamine (polyQ) are characteristically associated with insoluble neuronal inclusions, usually intranuclear, and neuronal death. We describe here oligomeric and polymeric aggregates formed in cells by expanded polyQ. These aggregates are not dissociated by concentrated formic acid, an extremely effective solvent for otherwise insoluble proteins. Perinuclear inclusions formed in cultured cells by expanded polyQ can be completely dissolved in concentrated formic acid, but a soluble protein oligomer containing the expanded polyQ and released by the formic acid is not dissociated to monomer. In Huntington's disease, a formic acid-resistant oligomer is present in cerebral cortex, but not in cerebellum. Cortical nuclei contain a polymeric aggregate of expanded polyQ that is insoluble in formic acid, does not enter polyacrylamide gels, but is retained on filters. This finding shows that the process of polymerization is more advanced in the cerebral cortex than in cultured cells. The resistance of oligomer and polymer to formic acid suggests the participation of covalent bonds in their stabilization.

1 April 2002 in Biochimie
Verified
Journal Article
Closed access
GHGuylaine Hoffner
Guylaine Hoffner
PDPhilippe Djian
Philippe Djian

1 January 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
ERErwann Rousseau
Erwann Rousseau
RKRieko Kojima
Rieko Kojima
GHGuylaine Hoffner
Guylaine Hoffner
PDPhilippe Djian
Philippe Djian
ABAnne Bertolotti
Anne Bertolotti
Deposition of misfolded proteins with a polyglutamine expansion is a hallmark of Huntington disease and other neurodegenerative disorders. Impairment of the proteolytic function of the proteasome has been reported to be both a cause and a consequence of polyglutamine accumulation. Here we found that the proteasomal chaperones that unfold proteins to be degraded by the proteasome but also have non-proteolytic functions co-localized with huntingtin inclusions both in primary neurons and in Huntington disease patients and formed a complex independently of the proteolytic particle. Overexpression of Rpt4 or Rpt6 facilitated aggregation of mutant huntingtin and ataxin-3 without affecting proteasomal degradation. Conversely, reducing Rpt6 or Rpt4 levels decreased the number of inclusions in primary neurons, indicating that endogenous Rpt4 and Rpt6 facilitate inclusion formation. In vitro reconstitution experiments revealed that purified 19S particles promote mutant huntingtin aggregation. When fused to the ornithine decarboxylase destabilizing sequence, proteins with expanded polyglutamine were efficiently degraded and did not aggregate. We propose that aggregation of proteins with expanded polyglutamine is not a consequence of a proteolytic failure of the 20S proteasome. Rather, aggregation is elicited by chaperone subunits of the 19S particle independently of proteolysis.

4 March 2013 in Analytical Chemistry
Verified
Journal Article
Closed access
WAWilliam André
William André
CSChristophe Sandt
Christophe Sandt
PDPaul Dumas
Paul Dumas
PDPhilippe Djian
Philippe Djian
GHGuylaine Hoffner
Guylaine Hoffner